05/05/2026
The emergence of recombinant African swine fever virus (ASFV) strains derived from genotypes I and II (rASFV I/II) poses a new challenge to the effectiveness of currently available vaccines in Viet Nam. A preliminary study conducted in experimental pigs by Nguyen Van Diep, Nguyen Van Duc, Vu Xuan Dang, Nguyen Thi Ngoc, Do Phuc Tue, Tran Ngoc Tiep (AVAC Vietnam Joint Stock Company), and Pham Ngoc Doanh (Institute of Biology, Vietnam Academy of Science and Technology) shows that the AVAC ASF LIVE vaccine confers cross-protective efficacy against this strain, with outcomes influenced by vaccination regimen and challenge dose.